Baijin Life Science HoldingsMNNGF 34 Altman Z-Score is 3.57 as of Jun. 28, 2026, which is 8% below its 10-year median of 3.89. GuruFocus rates MNNGF with a GF Score™ of 34/100 and a GF Value™ of $0.04. The stock has 6 warning signs investors should review. Among 1,113 Retail - Cyclical companies, Baijin Life Science Holdings ranks better than 66.13% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 3.62 is strong.
Baijin Life Science Holdings has a Altman Z-Score of 3.57, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Baijin Life Science Holdings's Altman Z-Score or its related term are showing as below:
MNNGF'
s Altman Z-Score Range Over the Past 10 Years
Min: -8.39 Med: 3.89 Max: 69.67
Current: 3.62
During the past 12 years, Baijin Life Science Holdings's highest Altman Z-Score was 69.67. The lowest was -8.39. And the median was 3.89.
Baijin Life Science Holdings (OTCPK:MNNGF) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Luxury Goods subindustry, Baijin Life Science Holdings's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings Altman Z-Score vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's Altman Z-Score falls into.
Baijin Life Science Holdings Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Baijin Life Science Holdings (MNNGF) has a Altman Z-Score of 3.57 as of Jun. 28, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Baijin Life Science Holdings and its competitors. This is near median its historical median of 3.89. According to the industry distribution chart, Baijin Life Science Holdings ranks #377 out of 1113 companies in the Retail - Cyclical industry, placing it in the top 33.9%.
Is Baijin Life Science Holdings' Altman Z-Score too high?
Baijin Life Science Holdings' current Altman Z-Score of 3.57 is near median its 10-year median of 3.89. The Retail - Cyclical industry median Altman Z-Score is 2.72. Baijin Life Science Holdings' value of 3.57 is 31.3% above this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #377 out of 1113 companies in the Retail - Cyclical industry, which is above the industry midpoint. Overall, Baijin Life Science Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Altman Z-Score compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #377 out of 1113 companies for Altman Z-Score. This puts Baijin Life Science Holdings in the upper half of its industry. The industry median Altman Z-Score is 2.72. Baijin Life Science Holdings' value of 3.57 is 31.3% above this benchmark. While the company's 10-year median is 3.89 vs. the industry median of 2.72, Baijin Life Science Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Retail - Cyclical company?
The median Altman Z-Score among Retail - Cyclical companies is 2.72, based on 1,113 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current Altman Z-Score of 3.57 is 31.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median Altman Z-Score is 2.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current Altman Z-Score is 3.57, which is near median its own 10-year median of 3.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Altman Z-Score of 3.57. The stock's GF Value™ is $0.04, compared to a current price of $0.08 — trading 87.5% above its estimated fair value. The current Altman Z-Score is 3.57, which is near median its 10-year median of 3.89 and 31.3% above the Retail - Cyclical industry median of 2.72. Baijin Life Science Holdings' overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Altman Z-Score is 3.57 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 87.5% above its estimated GF Value™ of $0.04.
Key valuation signals for MNNGF:
Altman Z-Score: 3.57 (near median its 10-year median of 3.89)
GF Value™: $0.04 vs. price of $0.08 (87.5% above fair value)
Industry Position: 31.3% above the Retail - Cyclical median (#377 of 1113)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
34GF Score
Get the complete analysis for MNNGF
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
